Showing results (1-10 of 541) with videos related to

Sort By:
Pageof 55
Clinical Epidemiology|May 6, 2022
A Framework for Visualizing Study Designs and Data Observability in Electronic Health Record DataShirley V Wang, Sebastian Schneeweiss
Clinical Pharmacology and Therapeutics|August 20, 2021
Assessing and Interpreting Real-World Evidence Studies: Introductory Points for New ReviewersShirley V Wang, Sebastian Schneeweiss
Diabetes, Obesity & Metabolism|April 7, 2020
Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetesElisabetta Patorno, Sebastian Schneeweiss, Shirley V Wang
Clinical Epidemiology|April 20, 2026
Adaptive Multi-Wave Sampling for Efficient Chart ValidationGeorg Hahn, Sebastian Schneeweiss, Shirley V Wang
Pharmacoepidemiology and Drug Safety|May 9, 2024
Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitorsShirley V Wang, Kueiyu Joshua Lin, Sebastian Schneeweiss
Nature Communications|August 31, 2022
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisionsShirley V Wang, Sushama Kattinakere Sreedhara, Sebastian Schneeweiss, et al.
BMJ Medicine|February 13, 2024
Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-DUPLICATE dataRachel Heyard, Leonhard Held, Sebastian Schneeweiss, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
DESIGN DIFFERENCES EXPLAIN VARIATION IN RESULTS BETWEEN RANDOMIZED TRIALS AND THEIR NON-RANDOMIZED EMULATIONSRachel Heyard, Leonhard Held, Sebastian Schneeweiss, et al.
Clinical Pharmacology and Therapeutics|February 24, 2026
Post hoc Population Standardization of Trial Emulation Studies in Claims Data: An RCT-DUPLICATE AnalysisPhyo Than Htoo, Elisabetta Patorno, Sebastian Schneeweiss, et al.
American Journal of Epidemiology|August 3, 2014
"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designsShirley V Wang, Sebastian Schneeweiss, Malcolm Maclure, et al.
Pageof 55